{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:58:45Z","timestamp":1774713525054,"version":"3.50.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cjca.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:04:57Z","timestamp":1765440297000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Evolving Landscape of Infective Endocarditis: Past, Present, and Future"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0184-4416","authenticated-orcid":false,"given":"Lawrence","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Messika-Zeitoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.12.009_bib1","first-page":"219","article-title":"Chronic infectious endocarditis","volume":"2","author":"Osler","year":"1909","journal-title":"Q J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry: a prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cjco.2021.02.015","article-title":"Injection drug use endocarditis: an inner-city hospital experience","volume":"3","author":"Syed","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.12.009_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjco.2021.07.014","article-title":"The epidemiology of endocarditis in manitoba: a retrospective study","volume":"3","author":"Maguire","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cjco.2020.05.002","article-title":"Epidemiology, microbiology, and clinical outcomes among patients with intravenous drug use-associated infective endocarditis in New Brunswick","volume":"2","author":"Mosseler","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.12.009_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/1469-0691.12166","article-title":"Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"19","author":"Chirouze","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cjca.2025.12.009_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacc.2022.11.028","article-title":"Infective endocarditis after transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"81","author":"Del Val","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib9","doi-asserted-by":"crossref","first-page":"e3750","DOI":"10.1093\/cid\/ciaa1941","article-title":"Temporal trends, characteristics, and outcomes of infective endocarditis after transcatheter aortic valve replacement","volume":"73","author":"Del Val","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib10","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jcin.2020.05.012","article-title":"Incidence, predictors, and outcomes of endocarditis after transcatheter aortic valve replacement in the United States","volume":"13","author":"Mentias","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.12.009_bib11","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.jacc.2020.04.044","article-title":"Infective endocarditis after transcatheter aortic valve replacement","volume":"75","author":"Stortecky","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9651","key":"10.1016\/j.cjca.2025.12.009_bib12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.12.009_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104455","article-title":"Patterns of drug use among people who inject drugs: a global systematic review and meta-analysis","volume":"128","author":"Webb","year":"2024","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.cjca.2025.12.009_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012465","article-title":"Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005-2014","volume":"9","author":"Mori","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib15","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1136\/heartjnl-2021-320652","article-title":"Clinical profile and outcome of recurrent infective endocarditis","volume":"108","author":"Citro","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.12.009_bib16","series-title":"A review of Canadian homelessness data 2023","author":"Dionne","year":"2023"},{"key":"10.1016\/j.cjca.2025.12.009_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciad706","article-title":"Bartonella quintana endocarditis: a systematic review of individual cases","volume":"78","author":"Boodman","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis\u2014Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cjca.2025.12.009_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2016.1235282","article-title":"Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis","volume":"49","author":"N\u2019Guyen","year":"2017","journal-title":"Ann Med"},{"issue":"4 pt 1","key":"10.1016\/j.cjca.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-94-4-505","article-title":"Infective endocarditis: an analysis based on strict case definitions","volume":"94","author":"von Reyn","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib25","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke-ISCVID criteria for infective endocarditis: updating the modified Duke Criteria","volume":"77","author":"Fowler","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s15010-024-02460-1","article-title":"Comparison of the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with positive blood cultures for new typical microorganisms","volume":"53","author":"Fourre","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.cjca.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ehjci\/jeae310","volume":"26","author":"Boufoula","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.12.009_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/cid\/ciae035","article-title":"Compared performance of the 2023 Duke\u2013International Society for Cardiovascular Infectious Diseases 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the diagnosis of infective endocarditis in a french multicenter prospective cohort","volume":"78","author":"Goehringer","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4322\/acr.2013.033","article-title":"Infective endocarditis: a history of the development of its understanding","volume":"3","author":"Geller","year":"2013","journal-title":"Autops Case Rep"},{"key":"10.1016\/j.cjca.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6","article-title":"Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption\/ionization with time-of-flight mass spectrometry","volume":"10","author":"Holland","year":"1996","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.cjca.2025.12.009_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/653675","article-title":"Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases","volume":"51","author":"Fournier","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib33","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1128\/JCM.00635-17","article-title":"Laboratory Diagnosis of infective endocarditis","volume":"55","author":"Liesman","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QCO.0000000000000009","article-title":"Fungal endocarditis","volume":"26","author":"Tacke","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2025.12.009_bib35","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/jac\/dkae275","article-title":"Evolving strategies in microbe identification-a comprehensive review of biochemical, MALDI-TOF MS and molecular testing methods","volume":"79","author":"Arbefeville","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cjca.2025.12.009_bib36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12879-016-1476-4","article-title":"Development and evaluation of a novel fast broad-range 16S ribosomal DNA PCR and sequencing assay for diagnosis of bacterial infective endocarditis: multi-year experience in a large Canadian healthcare zone and a literature review","volume":"16","author":"Miller","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib37","article-title":"16S rRNA gene PCR\/sequencing of heart valves for diagnosis of infective endocarditis in routine clinical practice","volume":"61","author":"Hong","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/cid\/ciab742","volume":"74","author":"Eichenberger","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib39","doi-asserted-by":"crossref","first-page":"e1492","DOI":"10.1093\/cid\/ciac426","article-title":"Microbial cell-free DNA identifies the causative pathogen in infective endocarditis and remains detectable longer than conventional blood culture in patients with prior antibiotic therapy","volume":"76","author":"Eichenberger","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib40","doi-asserted-by":"crossref","first-page":"e01315","DOI":"10.1128\/JCM.01315-19","article-title":"Third-generation sequencing in the clinical laboratory: exploring the advantages and challenges of nanopore sequencing","volume":"58","author":"Petersen","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12941-018-0294-5","article-title":"Identification of pathogens in culture-negative infective endocarditis cases by metagenomic analysis","volume":"17","author":"Cheng","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cjca.2025.12.009_bib42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.CIR.51.5.832","article-title":"Echocardiography manifestations of flail aortic valve leaflets in bacterial endocarditis","volume":"51","author":"Wray","year":"1975","journal-title":"Circulation"},{"issue":"7716","key":"10.1016\/j.cjca.2025.12.009_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(71)92300-2","article-title":"Urgent aortic-valve replacement for acute aortic regurgitation due to infective endocarditis","volume":"2","author":"Wise","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.12.009_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/153857447200600104","article-title":"Detection of fungal vegetations involving a Starr-Edwards mitral prosthesis by means of ultrasound","volume":"6","author":"Schelbert","year":"1972","journal-title":"Vasc Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archinte.1980.00330190034014","article-title":"Clinical value and limitations of echocardiography. Its use in the study of patients with infectious endocarditis","volume":"140","author":"Mintz","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib46","first-page":"247","article-title":"Echocardiography in infective endocarditis. Lack of specificity in patients with valvular pathology","volume":"10","author":"Markiewicz","year":"1979","journal-title":"Eur J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.CIR.60.4.728","article-title":"Comparison of M-mode and cross-sectional echocardiography in infective endocarditis","volume":"60","author":"Wann","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.12.009_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-8703(86)90687-3","article-title":"Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis","volume":"112","author":"Lutas","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0735-1097(91)90591-V","article-title":"Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis","volume":"18","author":"Shively","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/hrt.2003.031583","article-title":"Impact of harmonic imaging on transthoracic echocardiographic identification of infective endocarditis and its complications","volume":"91","author":"Chirillo","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.12.009_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101791","article-title":"Utility of intracardiac echocardiography for infective endocarditis and cardiovascular device-related endocarditis: a contemporary systematic review","volume":"48","author":"Sanchez-Nadales","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcct.2020.11.008","article-title":"Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: a contemporary comparative meta-analysis","volume":"15","author":"Jain","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.cjca.2025.12.009_bib53","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s12350-019-01963-x","article-title":"Added value of 18F-FDG-PET\/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis","volume":"28","author":"Wahadat","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib54","article-title":"Contemporary Approaches to the Use of Imaging in Infective Endocarditis","author":"Roque","year":"2025","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.cjca.2025.12.009_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.semnuclmed.2020.02.005","article-title":"The future of cardiac molecular imaging","volume":"50","author":"Farber","year":"2020","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib56","first-page":"436","article-title":"Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis","volume":"38","author":"Caobelli","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib57","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jcmg.2020.06.036","article-title":"ECG-gated cardiac FDG PET acquisitions significantly improve detectability of infective endocarditis","volume":"13","author":"Boursier","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.12.009_bib58","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1007\/s12350-021-02826-0","article-title":"Normal imaging findings after ascending aorta prosthesis implantation on 18F-fluorodeoxyglucose positron emission tomography with computed tomography","volume":"29","author":"Wahadat","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib59","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/ehjci\/jeab279","article-title":"The valve uptake index: improving assessment of prosthetic valve endocarditis and updating [18F]FDG PET\/CT(A) imaging criteria","volume":"23","author":"Roque","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.12.009_bib60","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCULATIONAHA.119.040228","article-title":"Multimodality imaging in infective endocarditis: an imaging team within the endocarditis team","volume":"140","author":"Erba","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.12.009_bib61","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cmi.2017.04.025","article-title":"Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","volume":"23","author":"Bai","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cjca.2025.12.009_bib62","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jcmg.2015.02.027","article-title":"Use of transthoracic echocardiography in the management of low-risk Staphylococcus aureus bacteremia: results from a retrospective multicenter cohort study","volume":"8","author":"Showler","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.12.009_bib63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.cmi.2018.03.027","article-title":"What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review","volume":"24","author":"Heriot","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cjca.2025.12.009_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101331","article-title":"Clinical risk factors for infective endocarditis patients with Staphylococcus Aureus bacteremia and the diagnostic utility of transesophageal echocardiogram","volume":"47","author":"Khan","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMp048179","article-title":"Producing penicillin","volume":"351","author":"Lerner","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/hrt.57.3.211","article-title":"Infective endocarditis 1937-1987","volume":"57","author":"Gray","year":"1987","journal-title":"Br Heart J"},{"issue":"4539","key":"10.1016\/j.cjca.2025.12.009_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.1.4539.1","article-title":"Penicillin in subacute bacterial endocarditis","volume":"1","author":"Christie","year":"1948","journal-title":"Br Med J"},{"issue":"7150","key":"10.1016\/j.cjca.2025.12.009_bib68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(60)91642-1","article-title":"Bacteriological studies on a new penicillin-BRL 1241","volume":"2","author":"Rolinson","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.12.009_bib69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM196602172740706","article-title":"Infective endocarditis in the antibiotic era","volume":"274","author":"Lerner","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib71","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis","volume":"56","author":"Fernandez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib72","doi-asserted-by":"crossref","first-page":"O1075","DOI":"10.1111\/1469-0691.12756","article-title":"Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone","volume":"20","author":"Pericas","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cjca.2025.12.009_bib73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/cid\/ciy279","article-title":"Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the general hospital of vienna","volume":"67","author":"Tobudic","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jgar.2024.06.002","article-title":"Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian Leadership on Antimicrobial Real-Life Usage) registry","volume":"38","author":"Zhanel","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.cjca.2025.12.009_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106072","article-title":"Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review","volume":"56","author":"Lampejo","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cjca.2025.12.009_bib76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14787210.2024.2374280","article-title":"How is ceftobiprole used in Canada: the CLEAR study final results","volume":"22","author":"Zhanel","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cjca.2025.12.009_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MAJ.0000000000000507","article-title":"The tale of infective endocarditis: fatal then curable but rarely preventable","volume":"350","author":"Smulyan","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cjca.2025.12.009_bib78","first-page":"161","article-title":"Infective endocarditis: past, present and future","volume":"6","author":"Weinstein","year":"1972","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/j.cjca.2025.12.009_bib79","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","article-title":"Early surgery versus conventional treatment for infective endocarditis","volume":"366","author":"Kang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib80","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtcvs.2014.06.019","article-title":"Residual patient, anatomic, and surgical obstacles in treating active left-side infective endocarditis","volume":"148","author":"Hussain","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib81","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2007-1014037","article-title":"Tricuspid valve endocarditis in the drug addict: a reconstructive approach (\u201cvegetectomy\u201d)","volume":"38","author":"Straumann","year":"1990","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib82","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jocs.14116","article-title":"Contemporary trends and outcomes of mitral valve surgery for infective endocarditis","volume":"34","author":"Alkhouli","year":"2019","journal-title":"J Card Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/jocs.13728","article-title":"Mitral valve repair or replacement in native valve endocarditis? Systematic review and meta-analysis","volume":"33","author":"Harky","year":"2018","journal-title":"J Card Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib84","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jtcvs.2018.04.064","article-title":"Nationwide cohort study of mitral valve repair versus replacement for infective endocarditis","volume":"156","author":"Lee","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib85","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/clc.23407","article-title":"Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years","volume":"43","author":"Hu","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/icvts\/ivz122","article-title":"Mechanical versus biological valve prosthesis for surgical aortic valve replacement in patients with infective endocarditis","volume":"29","author":"Kyto","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/14017431.2022.2079712","article-title":"Long-term outcomes of mechanical versus biological valve prosthesis in native mitral valve infective endocarditis","volume":"56","author":"Malmberg","year":"2022","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.cjca.2025.12.009_bib88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2011.05.021","article-title":"Surgical treatment for infective endocarditis in elderly patients","volume":"63","author":"Ramirez-Duque","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.cjca.2025.12.009_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020221","article-title":"Surgery is underused in elderly patients with left-side infective endocarditis: a nationwide registry study","volume":"10","author":"Ragnarsson","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib90","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.109.877365","article-title":"Age-dependent profile of left-side infective endocarditis: a 3-center experience","volume":"121","author":"Lopez","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.12.009_bib91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jcm11226693","article-title":"Mid- and long-term surgical outcomes due to infective endocarditis in elderly patients: a retrospective cohort study","volume":"11","author":"Jussli-Melchers","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib92","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s15010-022-01792-0","article-title":"Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry","volume":"50","author":"Pazdernik","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.cjca.2025.12.009_bib93","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2021.11.056","article-title":"Surgical treatment of patients with infective endocarditis after transcatheter aortic valve implantation","volume":"79","author":"Mangner","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib94","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010027","article-title":"Cardiac surgery compared with antibiotics only in patients developing infective endocarditis after transcatheter aortic valve replacement","volume":"7","author":"Mangner","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/cid\/ciab1004","article-title":"Perivalvular extension of infective endocarditis after transcatheter aortic valve replacement","volume":"75","author":"Panagides","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.21037\/acs-2024-etavr-0103","article-title":"Surgical management is associated with improved survival for endocarditis after transcatheter aortic valve replacement","volume":"14","author":"Fukuhara","year":"2025","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib97","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.athoracsur.2020.12.003","article-title":"Infective endocarditis secondary to injection drug use: a survey of Canadian cardiac surgeons","volume":"112","author":"An","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib98","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","article-title":"Injection drug use and outcomes after surgical intervention for infective endocarditis","volume":"100","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib99","first-page":"1416","article-title":"Making the cut: perspectives on the surgical management of infective endocarditis among people who use intravenous drugs","volume":"35","author":"Buchanan","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib100","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.amjcard.2017.08.051","article-title":"Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves","volume":"120","author":"Mylotte","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijcard.2022.10.136","article-title":"Infective endocarditis in adult patients with congenital heart disease","volume":"370","author":"van Melle","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib102","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/ejcts\/ezv223","article-title":"EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis","volume":"49","author":"Patrat-Delon","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib103","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.ijcard.2012.06.117","article-title":"Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of Cardiac Disease Registration (CADRE), a nation-wide survey in Japan","volume":"167","author":"Ohara","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib104","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/heartjnl-2016-311093","article-title":"Risk score for cardiac surgery in active left-sided infective endocarditis","volume":"103","author":"Olmos","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.12.009_bib105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025433","article-title":"Machine learning\u2013based risk model for predicting early mortality after surgery for infective endocarditis","volume":"11","author":"Luo","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib106","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/cid\/cix1000","article-title":"Mechanical thrombectomy for acute ischemic stroke secondary to infective endocarditis","volume":"66","author":"Ambrosioni","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101353","article-title":"AngioVac for vegetation debulking in right-sided infective endocarditis: a systematic review and meta-analysis","volume":"47","author":"Mhanna","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib108","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjmed.2024.04.031","article-title":"Comparison of medical therapy, valve surgery, and percutaneous mechanical aspiration for tricuspid valve infective endocarditis","volume":"137","author":"El-Dalati","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2025.12.009_bib109","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jtcvs.2021.09.023","article-title":"Surgical treatment of infective endocarditis at comprehensive versus primary valve centers","volume":"166","author":"Squiers","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309373","article-title":"Treating the disease and meeting the person with the illness-patient perspectives of needs during infective endocarditis, a qualitative study","volume":"19","author":"Lindberg","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2025.12.009_bib111","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001816","article-title":"Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study","volume":"94","author":"Munoz","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjca.2025.12.009_bib112","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40121-023-00763-8","article-title":"Epidemiological changes and improvement in outcomes of infective endocarditis in europe in the twenty-first century: an International Collaboration on Endocarditis (ICE) prospective cohort study (2000-2012)","volume":"12","author":"Ambrosioni","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cjca.2025.12.009_bib113","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.athoracsur.2011.10.063","article-title":"Outcomes after surgical treatment of native and prosthetic valve infective endocarditis","volume":"93","author":"Manne","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2025.12.009_bib114","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/eurjpc\/zwab184","article-title":"Global magnitude and temporal trend of infective endocarditis 1990-2019: results from the Global Burden of Disease Study","volume":"29","author":"Yang","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12872-025-04633-8","article-title":"Temporal trends, clinical characteristics and prognostic factors analysis of infective endocarditis: a multicenter ambispective cohort study in China","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2025.12.009_bib116","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037188","article-title":"Trends in the clinical characteristics and outcome of infective endocarditis: a nationwide study from 2016 to 2021","volume":"14","author":"Okamoto","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjcard.2023.07.018","article-title":"Gender, age, and regional disparities in the incidence and mortality trends of infective endocarditis in the United States between 1990 and 2019","volume":"203","author":"Mettler","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ehjqcco\/qcac011","article-title":"Temporal trends of mortality in patients with infective endocarditis: a nationwide study","volume":"9","author":"Jensen","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2025.12.009_bib119","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijcard.2022.09.061","article-title":"Trends in the incidence and mortality of infective endocarditis in high-income countries between 1990 and 2019","volume":"371","author":"Hammond-Haley","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.12.009_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031589","article-title":"Trends in infective endocarditis mortality in the United States: 1999 to 2020: a cause for alarm","volume":"12","author":"Chobufo","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.12.009_bib122","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jama.2025.4288","article-title":"Management of Staphylococcus aureus bacteremia: a review","volume":"334","author":"Tong","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.12.009_bib123","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2020.05.012","article-title":"Accelerated treatment of endocarditis\u2014the POET II trial: rationale and design of a randomized controlled trial","volume":"227","author":"Ostergaard","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2025.12.009_bib124","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus Network Adaptive Platform Trial Protocol: new tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2025.12.009_bib125","doi-asserted-by":"crossref","unstructured":"Turner NA, Hamasaki T, Doernberg SB, et al. Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial. JAMA. doi:10.1001\/jama.2025.12543 [e-pub ahead of print].","DOI":"10.1001\/jama.2025.12543"},{"key":"10.1016\/j.cjca.2025.12.009_bib126","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1093\/eurheartj\/ehad715","article-title":"Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study","volume":"44","author":"Pries-Heje","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25015697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25015697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:31:13Z","timestamp":1774711873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25015697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0828282X25015697"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.12.009","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evolving Landscape of Infective Endocarditis: Past, Present, and Future","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}